Literature DB >> 20883225

Meta-analysis concludes angiotensin receptor blocker use increases the risk of developing cancer: concerns about the science and the message.

Michael J Bloch, Jan N Basile.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20883225      PMCID： PMC8673368          DOI： 10.1111/j.1751-7176.2010.00369.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  3 in total

Review 1.  Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.

Authors:  Ilke Sipahi; Sara M Debanne; Douglas Y Rowland; Daniel I Simon; James C Fang
Journal:  Lancet Oncol       Date:  2010-06-11       Impact factor: 41.316

2.  Angiotensin-receptor blockers and cancer: urgent regulatory review needed.

Authors:  Steven E Nissen
Journal:  Lancet Oncol       Date:  2010-06-11       Impact factor: 41.316

3.  Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

Authors:  Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren; Salim Yusuf; Stuart Pocock
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321
  3 in total
  1 in total

1.  Angiotensin and systems thinking: wrapping your mind around the big picture.

Authors:  Gary Robert Smith
Journal:  Ochsner J       Date:  2013
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.